Table 2.
Demographic and clinicopathological characteristics.
| Characteristics | Count (%) |
|---|---|
| Goiter | |
| Single | 36 (23.1%) |
| Multinodular | 120 (76.9%) |
|
| |
| T | |
| T1 | 61 (17.8%) |
| T2 | 22 (6.4%) |
| T3 | 195 (56.9%) |
| T4a | 43 (12.5%) |
| T4b | 22 (6.4%) |
|
| |
| N | |
| Nx | 126 (36.7%) |
| N0 | 31 (9.0%) |
| N1a | 30 (8.7%) |
| N1b | 156 (45.5%) |
|
| |
| M | |
| Mx or M0 | 331 (96.5%) |
| M1 | 12 (3.5%) |
|
| |
| Capsular invasion | |
| No | 38 (39.6%) |
| Yes | 58 (60.4%) |
|
| |
| Vascular invasion | |
| No | 125 (83.9%) |
| Yes | 24 (16.1%) |
|
| |
| Perineural invasion | |
| No | 25 (78.1%) |
| Yes | 7 (21.9%) |
|
| |
| Lymph node metastasis (LNM) | |
| No LNM | 65 (27.5%) |
| LNM at initial presentation | 54 (22.9%) |
| Regional lymph node recurrence | 117 (49.6%) |